Green Thumb Industries (GTBIF) Intangibles (2019 - 2026)
Green Thumb Industries (GTBIF) posted Intangibles of $424.1 million for Q1 2026, down 2.88% on a QoQ basis from $436.7 million in Q4 2025, and down 10.85% year-over-year from $475.7 million in Q1 2025.
Green Thumb Industries (GTBIF) Intangibles (2019 - 2026) Analysis & Trends
Green Thumb Industries' Intangibles history runs 8 years deep, the most recent figure standing at $424.1 million for Q1 2026.
- Quarterly Intangibles fell 10.85% year-over-year to $424.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $424.1 million (down 10.85% YoY) and the FY2025 annual result came in at $436.7 million, down 10.57% from the prior year.
- Intangibles was $424.1 million for Q1 2026 at Green Thumb Industries, down from $436.7 million in the prior quarter.
- Across five years, Intangibles topped out at $674.7 million in Q1 2022 and bottomed at $424.1 million in Q1 2026.
- A 5-year average of $533.3 million and a median of $526.0 million in 2024 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2022 — Intangibles jumped 70.37% — and 2023, when it retreated 14.49%.
- Green Thumb Industries' Intangibles stood at $589.5 million in 2022, then declined by 8.62% to $538.7 million in 2023, then fell by 9.35% to $488.3 million in 2024, then declined by 10.57% to $436.7 million in 2025, then slipped by 2.88% to $424.1 million in 2026.
- Business Quant data shows GTBIF's Intangibles at $424.1 million in Q1 2026, $436.7 million in Q4 2025, and $442.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 34.07 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 959.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 21.80 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 473.93 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.48 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.23 Bn |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn | 424.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 424.11 Mn |
| Dec 31, 2025 | 436.68 Mn |
| Sep 30, 2025 | 442.73 Mn |
| Jun 30, 2025 | 462.41 Mn |
| Mar 31, 2025 | 475.71 Mn |
| Dec 31, 2024 | 488.29 Mn |
| Sep 30, 2024 | 500.86 Mn |
| Jun 30, 2024 | 513.43 Mn |
| Mar 31, 2024 | 526.01 Mn |
| Dec 31, 2023 | 538.68 Mn |
| Sep 30, 2023 | 551.42 Mn |
| Jun 30, 2023 | 564.17 Mn |
| Mar 31, 2023 | 576.91 Mn |
| Dec 31, 2022 | 589.52 Mn |
| Sep 30, 2022 | 640.99 Mn |
| Jun 30, 2022 | 659.60 Mn |
| Mar 31, 2022 | 674.69 Mn |
| Dec 31, 2021 | 675.49 Mn |
| Sep 30, 2021 | 549.18 Mn |
| Jun 30, 2021 | 411.54 Mn |